WASHINGTON (Reuters) - A clinical reviewer from the U.S. Food and Drug Administration on Tuesday recommended the agency approve Cornerstone Therapeutics Inc's drug to treat low sodium levels in one condition.
via Reuters: Health News Read More Here..
No comments:
Post a Comment